DSV Panalpina A/S
DSV, 864 - SHARE BUYBACK IN DSV PANALPINA A/S
Company Announcement No. 864
On 29 October 2020, we initiated a share buyback programme of DKK 6,000 million running until 30 April 2021, as described in Company Announcement No. 842. On 10 February 2021 the maximum aggregate purchase price of the shares to be bought back under the programme was increased to DKK 8,000 million.
According to the programme, the company will in the period from 29 October 2020 to 30 April 2021 purchase own shares up to a maximum value of DKK 8,000 million and no more than 12 million shares, corresponding to 5.22% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.
|Trading day||Number of shares bought back||Average transaction price||Amount DKK|
|Accumulated trading for days 1-68||3,958,522||1,006.90||3,985,816,196|
|69:||8 February 2021||47,936||1,024.76||49,122,924|
|70:||9 February 2021||47,000||1,024.91||48,170,855|
|71:||10 February 2021||107,500||1,026.55||110,354,437|
|72:||11 February 2021||52,000||1,058.85||55,060,314|
|73:||12 February 2021||65,000||1,103.25||71,710,964|
|Accumulated trading for days 1-73||4,277,958||1,009.88||4,320,235,690|
As at today, DSV Panalpina A/S holds a total of 6,088,474 shares of a nominal value of DKK 1 in DSV Panalpina A/S, corresponding to 2.65% of the total number of issued shares of 230,000,000.
The details of each transaction made under the share buyback programme are published on investor.dsv.com.
Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.
DSV Panalpina A/S
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Junshi Biosciences1.3.2021 02:16:51 CET | Press release
Junshi Biosciences and AstraZeneca Announce Strategic Collaboration to Commercialize Toripalimab in China
Anoto Group AB28.2.2021 23:46:27 CET | Press release
Year-end report January – December 2020
European Energy A/S28.2.2021 22:27:15 CET | Press release
European Energy A/S: Interim Financial Report Q4 2020
European Energy A/S28.2.2021 21:46:34 CET | Press release
European Energy A/S: Annual Report 2020
Belships ASA28.2.2021 19:48:50 CET | Press release
Belships expands fleet with two new Ultramax bulk carriers
Prosafe SE27.2.2021 14:08:54 CET | Press release
Prosafe SE: Safe Boreas to provide accommodation support at Buzzard
BW Offshore27.2.2021 11:01:34 CET | Press release
BW Offshore: Long-Term Incentive Programme new awards
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom